BIOMAT Database Logo BIOMAT Database Logo

Penetration characteristics of trimethoprim-sulfamethoxazole in middle ear fluid of patients with chronic serous otitis media. 1980

J J Klimek, and T R Bates, and C Nightingale, and W B Lehmann, and J A Ziemniak, and R Quintiliani

UI MeSH Term Description Entries
D010033 Otitis Media Inflammation of the MIDDLE EAR including the AUDITORY OSSICLES and the EUSTACHIAN TUBE. Middle Ear Inflammation,Inflammation, Middle Ear
D010034 Otitis Media with Effusion Inflammation of the middle ear with a clear pale yellow-colored transudate. Middle Ear Effusion,Otitis Media, Secretory,Otitis Media, Serous,Ear Effusion, Middle,Ear Effusions, Middle,Effusion, Middle Ear,Effusions, Middle Ear,Middle Ear Effusions,Secretory Otitis Media,Serous Otitis Media
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D005122 Exudates and Transudates Exudates are fluids, CELLS, or other cellular substances that are slowly discharged from BLOOD VESSELS usually from inflamed tissues. Transudates are fluids that pass through a membrane or squeeze through tissue or into the EXTRACELLULAR SPACE of TISSUES. Transudates are thin and watery and contain few cells or PROTEINS. Transudates,Exudates,Transudates and Exudates,Exudate,Transudate
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013420 Sulfamethoxazole A bacteriostatic antibacterial agent that interferes with folic acid synthesis in susceptible bacteria. Its broad spectrum of activity has been limited by the development of resistance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p208) Sulfamethylisoxazole,Gantanol,Sulfisomezole,Sulphamethoxazole
D014295 Trimethoprim A pyrimidine inhibitor of dihydrofolate reductase, it is an antibacterial related to PYRIMETHAMINE. It is potentiated by SULFONAMIDES and the TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION is the form most often used. It is sometimes used alone as an antimalarial. TRIMETHOPRIM RESISTANCE has been reported. Proloprim,Trimpex

Related Publications

J J Klimek, and T R Bates, and C Nightingale, and W B Lehmann, and J A Ziemniak, and R Quintiliani
Penetration of amoxicillin, cefaclor, erythromycin-sulfisoxazole, and trimethoprim-sulfamethoxazole into the middle ear fluid of patients with chronic serous otitis media.
June 1982, The Journal of infectious diseases,
J J Klimek, and T R Bates, and C Nightingale, and W B Lehmann, and J A Ziemniak, and R Quintiliani
Penetration of erythromycin to middle ear fluid of patients with chronic serous otitis media.
June 1983, The Journal of infectious diseases,
J J Klimek, and T R Bates, and C Nightingale, and W B Lehmann, and J A Ziemniak, and R Quintiliani
Penetration of trimethoprim--sulfadiazine into middle ear fluid in secretory otitis media.
September 1983, International journal of pediatric otorhinolaryngology,
J J Klimek, and T R Bates, and C Nightingale, and W B Lehmann, and J A Ziemniak, and R Quintiliani
Penetration of cefprozil into middle ear fluid of patients with otitis media.
September 1994, Antimicrobial agents and chemotherapy,
J J Klimek, and T R Bates, and C Nightingale, and W B Lehmann, and J A Ziemniak, and R Quintiliani
Activity of trimethoprim-sulfamethoxazole against middle ear fluid pathogens obtained from Costa Rican children with otitis media.
September 2005, The Pediatric infectious disease journal,
J J Klimek, and T R Bates, and C Nightingale, and W B Lehmann, and J A Ziemniak, and R Quintiliani
Penetration of cefpodoxime into middle ear fluid in pediatric patients with acute otitis media.
January 1997, The Pediatric infectious disease journal,
J J Klimek, and T R Bates, and C Nightingale, and W B Lehmann, and J A Ziemniak, and R Quintiliani
Middle ear fluid characteristics in pediatric otitis media with effusion.
December 2012, International journal of pediatric otorhinolaryngology,
J J Klimek, and T R Bates, and C Nightingale, and W B Lehmann, and J A Ziemniak, and R Quintiliani
Amoxicillin middle ear fluid penetration and pharmacokinetics in children with acute otitis media.
December 1998, Clinical pediatrics,
J J Klimek, and T R Bates, and C Nightingale, and W B Lehmann, and J A Ziemniak, and R Quintiliani
Amoxicillin middle ear fluid penetration and pharmacokinetics in children with acute otitis media.
February 1998, The Pediatric infectious disease journal,
J J Klimek, and T R Bates, and C Nightingale, and W B Lehmann, and J A Ziemniak, and R Quintiliani
Penetration of ceftazidime into middle ear fluid in children with otitis media with effusion.
May 1998, The Laryngoscope,
Copied contents to your clipboard!